Success Metrics

Completion Rate
0%(0/3)
Active Trials
0(0%)
Terminated
3(100%)

Phase Distribution

Ph phase_3
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
3(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(3)

Detailed Status

Terminated3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 33 (100.0%)

Trials by Status

terminated3100%

Recent Activity

0 active trials
Showing 3 of 3
terminatedphase_3

A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety

NCT00375401
terminatedphase_3

A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients

NCT00391196
terminatedphase_3

Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.

NCT00396448

Clinical Trials (3)

Showing 3 of 3 trials
NCT00375401Phase 3

A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety

Terminated
NCT00391196Phase 3

A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients

Terminated
NCT00396448Phase 3

Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3